Chemed (CHE) to Release Earnings on Wednesday

Chemed (NYSE:CHEGet Free Report) will post its quarterly earnings results after the market closes on Wednesday, April 24th. Analysts expect Chemed to post earnings of $5.09 per share for the quarter. Chemed has set its FY24 guidance at $23.30-$23.70 EPS and its FY 2024 guidance at 23.300-23.700 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Chemed (NYSE:CHEGet Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $6.60 earnings per share for the quarter, beating the consensus estimate of $6.25 by $0.35. The business had revenue of $585.90 million for the quarter, compared to the consensus estimate of $586.64 million. Chemed had a return on equity of 32.29% and a net margin of 12.03%. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.39 EPS. On average, analysts expect Chemed to post $22 EPS for the current fiscal year and $24 EPS for the next fiscal year.

Chemed Stock Up 0.7 %

Shares of CHE stock opened at $604.56 on Tuesday. The stock has a market cap of $9.14 billion, a PE ratio of 33.74, a price-to-earnings-growth ratio of 2.41 and a beta of 0.42. The business has a 50-day simple moving average of $622.33 and a 200-day simple moving average of $589.76. Chemed has a 52-week low of $492.84 and a 52-week high of $654.62.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were issued a $0.40 dividend. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $1.60 annualized dividend and a dividend yield of 0.26%. Chemed’s dividend payout ratio (DPR) is presently 8.93%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CHE. Royal Bank of Canada boosted their price objective on Chemed from $604.00 to $712.00 and gave the company an “outperform” rating in a report on Monday, March 4th. Oppenheimer upped their price target on Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Thursday, February 29th.

Check Out Our Latest Stock Analysis on CHE

Insider Buying and Selling at Chemed

In other Chemed news, EVP Spencer S. Lee sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the transaction, the executive vice president now owns 20,760 shares of the company’s stock, valued at $13,320,654. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Michael D. Witzeman sold 2,650 shares of the company’s stock in a transaction that occurred on Thursday, March 21st. The stock was sold at an average price of $643.14, for a total value of $1,704,321.00. Following the completion of the sale, the chief financial officer now directly owns 2,882 shares in the company, valued at $1,853,529.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Spencer S. Lee sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, March 28th. The shares were sold at an average price of $641.65, for a total value of $1,283,300.00. Following the completion of the sale, the executive vice president now owns 20,760 shares of the company’s stock, valued at $13,320,654. The disclosure for this sale can be found here. Insiders sold 15,808 shares of company stock valued at $10,184,531 over the last quarter. 4.03% of the stock is currently owned by insiders.

Chemed Company Profile

(Get Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

See Also

Earnings History for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.